These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 995035)

  • 21. [Calcification in the conjunctiva and cornea in chronic renal insufficiency and haemodialysis (author's transl)].
    Hanselmayer H; Pogglitsch H; Schmidberger H
    Klin Monbl Augenheilkd; 1974 Jan; 164(1):98-105. PubMed ID: 4825034
    [No Abstract]   [Full Text] [Related]  

  • 22. [Calcium intoxication and septicemia in terminal renal insufficiency with renal osteodystrophy (author's transl)].
    Haas HG; Zollinger HU; Heer K; Thölen H
    Schweiz Rundsch Med Prax; 1978 Sep; 67(36):1306-16. PubMed ID: 683960
    [No Abstract]   [Full Text] [Related]  

  • 23. [Plasma hydroxyproline determination in patients with metabolic diseases of the bone collagen].
    Leicht E; Langer HJ; Stelzer K; Blum C
    Verh Dtsch Ges Inn Med; 1978; (84):1115-9. PubMed ID: 741900
    [No Abstract]   [Full Text] [Related]  

  • 24. Parathyroid suppressibility in renal osteodystrophy.
    Moorhead JF; Varghese Z; Tatler GL; Baillod RA; Ku G; Sweatman AJ; Wills MR
    Proc Eur Dial Transplant Assoc; 1975; 11():465-72. PubMed ID: 1197271
    [No Abstract]   [Full Text] [Related]  

  • 25. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propranolol and uraemic osteodystrophy.
    Brancaccio D; Galmozzi C; Casati S; Rurale D; Belloli S; Aroldi A; Graziani G; Ponticelli C
    Proc Eur Dial Transplant Assoc; 1979; 16():668-71. PubMed ID: 549007
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical significance of free plasma hydroxyproline measurement in metabolic bone disease.
    Minisola S; Antonelli R; Mazzuoli G
    J Clin Chem Clin Biochem; 1985 Sep; 23(9):515-9. PubMed ID: 4067520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
    Pogglitsch H; Schmidberger H; Gell G
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):131-6. PubMed ID: 814443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The bony scan at 99m Tc pyrophosphate in the chronic kidney deficiency treated by hemodialysis (author's transl)].
    Cledes J; Paille R; Jacolot G; Morin JF; Caroff J
    Sem Hop; 1980 Jan 8-15; 56(1-2):7-10. PubMed ID: 6244634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of hydroxy-DL-proline-2-(14)C in the investigation of hydroxyproline metabolism in normal subjects and in patients with renal insufficiency.
    Hart W; van den Hamer CJ; van der Sluys Veer J
    Clin Nephrol; 1976 Sep; 6(3):379-87. PubMed ID: 991465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum and urinary hydroxyproline in patients with severe chronic renal failure.
    Jungiewicz R; Tomaszewski J
    Ann Univ Mariae Curie Sklodowska Med; 1986; 41():67-73. PubMed ID: 3154061
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute responsiveness to calcitonin in chronic renal failure.
    Cochran M; Hillyard CJ; Dew GJ; Martin TJ
    Br Med J; 1976 Aug; 2(6032):396-8. PubMed ID: 947443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rise in serum creatinine under the androgen fluoxymesterone in chronic renal disease (author's transl)].
    Schulz E; Heinecke G
    MMW Munch Med Wochenschr; 1976 Nov; 118(48):1559-62. PubMed ID: 826797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of progressive end-stage renal insufficiency on bone mineral-collagen maturation.
    Russell JE; Avioli LV
    Kidney Int Suppl; 1975 Jan; (2):97-101. PubMed ID: 1099309
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma calcium fraction dynamics in uremic patients undergoing hemodialysis.
    Asad SN; Olmer AJ; Letteri JM
    Miner Electrolyte Metab; 1984; 10(5):333-6. PubMed ID: 6493162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effects of 25-hydroxycholecalciferol in patients with chronic renal failure.
    Matsushita Y; Hasegawa K; Otomo S; Morii H; Okamoto T
    J Nutr Sci Vitaminol (Tokyo); 1977; 23(3):257-61. PubMed ID: 915557
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on abnormalities of calcium, vitamin D and bone metabolism in patients on maintenance hemodialysis (author's transl)].
    Kitoh C
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):503-18. PubMed ID: 529620
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
    O'Riordan JL; Page J; Kerr DN; Walls J; Moorhead J; Crockett RE; Franz H; Ritz E
    Q J Med; 1970 Jul; 39(155):359-76. PubMed ID: 5478506
    [No Abstract]   [Full Text] [Related]  

  • 40. Pregnancy-associated plasma protein A in dialysis patients.
    Coskun A; Bicik Z; Duran S; Alcelik A; Soypacaci Z; Yavuz O; Oksuz S
    Clin Chem Lab Med; 2007; 45(1):63-6. PubMed ID: 17243917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.